Total Funding
66
52
Total FundingPost-IPO Debt raised
Growth Score 66 in past quarter
-10 pts
Heat Score 52 in past quarter
-8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
106239
Sanara MedTech develop, market, and distribute biotechnology products to physicians, hospitals, clinics and all post-acute care settings.
- Kenneth E. Thorpe: Founder & Director
- Zach Fleming: CEOPast Role: Sanara MedTech, Vice President Sales
About the Company
With their focus on improving patient outcomes with evidence-based healing solutions, they develop, market and distribute biotechnology products to physicians, hospitals, clinics and all post-acute care settings. They are constantly seeking long-term partnerships with a focus on products that produce efficacious outcomes at a lower overall cost.
Their products are primarily sold in the North American surgical tissue repair and advanced wound care markets.
